BusinessPhoto: Fortune IndiaOmron CEO Says Apple Not a Threat to BP Device Business
Omron Corp's CEO Junta Tsujinaga stated that Apple poses no threat to Omron's blood pressure (BP) device business. In fiscal year 2026, blood pressure monitors accounted for 72% of Omron's healthcare business revenue, totaling $967 million. This highlights Omron's strong market position in healthcare devices despite competition from tech companies.
Fortune India·



